Cart
sales@molnova.com
Propargyl-C1-NHS ester
CAS No. 132178-37-1
Propargyl-C1-NHS ester( 4-Pentynoic Acid Succinimidyl Ester )
Catalog No. M27002 CAS No. 132178-37-1
Propargyl-C1-NHS ester is a nonclaevable linker for antibody-drug-conjugation (ADC).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 29 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 63 | In Stock |
|
| 100MG | 72 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePropargyl-C1-NHS ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionPropargyl-C1-NHS ester is a nonclaevable linker for antibody-drug-conjugation (ADC).
-
DescriptionPropargyl-C1-NHS ester is a nonclaevable linker for antibody-drug-conjugation (ADC).
-
In Vitro——
-
In Vivo——
-
Synonyms4-Pentynoic Acid Succinimidyl Ester
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number132178-37-1
-
Formula Weight195.174
-
Molecular FormulaC9H9NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (512.37 mM)
-
SMILESO=C(CCC#C)ON1C(=O)CCC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lu X, et al. Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach. Bioorg Med Chem. 2016 Sep 15;24(18):4424-4433.
molnova catalog
related products
-
Thalidomide-O-amido-...
Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
-
3,4-Dimethoxycinnamy...
3,4-Dimethoxycinnamyl alcohol shows significant antimicrobial and cytotoxic activities.
-
4-Borono-L-phenylala...
4-Borono-L-phenylalanine has antitumor activity and may be used in clinical trials of boron neutron capture therapy for the treatment of melanoma and glioblastoma multiforme.
